Today, new-generation cancer drugs have significantly improved both effectiveness and safety, especially targeted therapies.
11d
Exclusive-US FDA Taps Merck Drugs With Blockbuster Sales Potential for National Priority Vouchers
Merck's cholesterol pill enlicitide decanoate and its cancer therapy sacituzumab tirumotecan, or sac-TMT, have been tapped ...
Vial, a clinical-stage biotech company, today announced growing enthusiasm among metabolic disease KOLs for Vial's INHBE siRNA, a first-in-class, liver-targeted (GalNAc-conjugated) siRNA therapy that ...
Halozyme HALO3.44%increase; green up pointing triangle was granted a preliminary injunction that would prevent Merck MRK 0.40%increase; green up pointing triangle & Co. from distributing a formulation ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
On the heels of striking a deal with the Trump administration to reduce the prices of several of its most popular drugs for U.S. patients, Eli Lilly has unveiled additional savings for cash-paying ...
Dec 1 (Reuters) – Eli Lilly said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more affordable for U.S. patients, as demand for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback